- Home
- XRTX vs ATXG Comparison
XRTX vs ATXG Comparison
Compare XRTX & ATXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- ATXG
- Stock Information
- Founded
- XRTX 2011
- ATXG 2014
- Country
- XRTX Canada
- ATXG China
- Employees
- XRTX N/A
- ATXG N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- ATXG Professional Services
- Sector
- XRTX Health Care
- ATXG Consumer Discretionary
- Exchange
- XRTX Nasdaq
- ATXG Nasdaq
- Market Cap
- XRTX 4.5M
- ATXG 3.8M
- IPO Year
- XRTX N/A
- ATXG N/A
- Fundamental
- Price
- XRTX $0.90
- ATXG $1.01
- Analyst Decision
- XRTX
- ATXG
- Analyst Count
- XRTX 0
- ATXG 0
- Target Price
- XRTX N/A
- ATXG N/A
- AVG Volume (30 Days)
- XRTX 46.7K
- ATXG 1.1M
- Earning Date
- XRTX 11-14-2025
- ATXG 11-13-2025
- Dividend Yield
- XRTX N/A
- ATXG N/A
- EPS Growth
- XRTX N/A
- ATXG N/A
- EPS
- XRTX N/A
- ATXG N/A
- Revenue
- XRTX N/A
- ATXG $4,310,835.00
- Revenue This Year
- XRTX N/A
- ATXG N/A
- Revenue Next Year
- XRTX N/A
- ATXG N/A
- P/E Ratio
- XRTX N/A
- ATXG N/A
- Revenue Growth
- XRTX N/A
- ATXG N/A
- 52 Week Low
- XRTX $0.66
- ATXG $0.36
- 52 Week High
- XRTX $2.51
- ATXG $1.86
- Technical
- Relative Strength Index (RSI)
- XRTX 59.28
- ATXG 63.44
- Support Level
- XRTX $0.79
- ATXG $0.82
- Resistance Level
- XRTX $0.91
- ATXG $1.17
- Average True Range (ATR)
- XRTX 0.03
- ATXG 0.16
- MACD
- XRTX 0.01
- ATXG 0.00
- Stochastic Oscillator
- XRTX 92.67
- ATXG 56.90
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.